THE DEAL, AT A GLANCE
From the announcementConcordare
01What it does"Every day a trial runs late, a patient is waiting," said Zach Sawaged, CEO and founder of Concordare Trials.From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗02Who is involvedBacked by Surface Ventures, Techstars, Innovation Works, GaingelsFrom the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗03What happenedConcordare raised $25M Seed, announced 2026-08-25From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗04Why it mattersConcordare is positioned around digitizing clinical trial protocols at an early point in the process, with a stated opportunity to further digitize the clinical trial…From the announcement
Summarized from the deal record's source announcement; not yet independently reviewed.
Read the announcement ↗Click a part to explore its evidence. Unsupported imagery is withheld rather than guessed.Original record source ↗
Concordare · Financing Record
Explore source-linked visual explanations for Concordare. Unsupported claims are withheld while source review continues.
Record 11274 · Recorded date: 2026-08-25
Explore company records →